TickerFacts.

Castle Biosciences Inc (CSTL): Operating Cash Flow

Annual figures by period end, from SEC filings.

$64.35M
Year ended 2025-12-31
$42.63M
Trailing 12 months to 2026-06-30
+45.5%
5-year compound annual growth
$64.87M2018-12-31: -$12.29M2019-12-31: $7.01M2020-12-31: $9.87M2021-12-31: -$18.98M2022-12-31: -$41.66M2023-12-31: -$5.63M2024-12-31: $64.87M2025-12-31: $64.35M$64.35M
2018-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$64.35M-0.8%2026-02-26, From 2025-01-01
2024-12-31$64.87Mn/m2026-02-26, From 2024-01-01
2023-12-31-$5.63Mn/m2026-02-26, From 2023-01-01
2022-12-31-$41.66Mn/m2025-02-27, From 2022-01-01
2021-12-31-$18.98Mn/m2023-02-28, From 2021-01-01
2020-12-31$9.87M+40.6%2022-02-28, From 2020-01-01
2019-12-31$7.01Mn/m2021-03-11, From 2019-01-01
2018-12-31-$12.29Mn/a2020-03-10, From 2018-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Castle Biosciences Inc (CSTL)2025-12-31$64.35M-0.8%
Fulgent Genetics, Inc. (FLGT)2025-12-31-$101.64Mn/m
CareDx, Inc. (CDNA)2025-12-31$42.03M+10.5%
BillionToOne, Inc. (BLLN)2025-12-31$24.59Mn/m
Veracyte, Inc. (VCYT)2025-12-31$136.31M+81.5%
GRAIL, Inc. (GRAL)2025-12-31-$299.01Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$83.16Mn/m
Guardant Health, Inc. (GH)2025-12-31-$184.76Mn/m
Biodesix Inc (BDSX)2025-12-31-$23.27Mn/m

Compare CSTL, FLGT, CDNA, BLLN side by side · Screen every company in Services-Medical Laboratories ↗